Publications

• Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma.
  Ally, M. S., Ransohoff, K., Sarin, K., Atwood, S. X., Rezaee, M., & Colevas, A. D. (2016). Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma. JAMA dermatology, 1-5.
• Squamous Change in Basal-Cell Carcinoma with Drug Resistance.
  Ransohoff, K. J., Tang, J. Y., & Sarin, K. Y. (2015). Squamous Change in Basal-Cell Carcinoma with Drug Resistance. New England journal of medicine, 373(11), 1079-1082.
• Smoothened Variants Explain the Majority of Drug Resistance in Basal Cell Carcinoma
  Atwood, S. X., Sarin, K. Y., Whitson, R. J., Li, J. R., Kim, G., & Tang, J. Y. (2015). Smoothened Variants Explain the Majority of Drug Resistance in Basal Cell Carcinoma. CANCER CELL, 27(3), 342-353.
• Genomic Analysis of Smoothened Inhibitor Resistance in Basal Cell Carcinoma Sharpe, H. J., Pau, G., Dijkgraaf, G. J., Basset-Seguin, N., Modrusan, Z., & de Sauvage, F. J. (2015). Genomic Analysis of Smoothened Inhibitor Resistance in Basal Cell Carcinoma. CANCER CELL, 27(3), 327-341.
  
• Open-Label, Exploratory Phase II Trial of Oral Itraconazole for the Treatment of Basal Cell Carcinoma Kim, D. J., Kim, J., Spaunhurst, K., Montoya, J., Khodosh, R., & Tang, J. Y. (2014). Open-Label, Exploratory Phase II Trial of Oral Itraconazole for the Treatment of Basal Cell Carcinoma. JOURNAL OF CLINICAL ONCOLOGY, 32(8), 745-751.
  
• Inhibiting the Hedgehog Pathway in Patients with the Basal-Cell Nevus Syndrome Tang, J. Y., Mackay-Wiggan, J. M., Aszterbaum, M., Yauch, R. L., Lindgren, J., & Epstein, E. H. (2012). Inhibiting the Hedgehog Pathway in Patients with the Basal-Cell Nevus Syndrome. NEW ENGLAND JOURNAL OF MEDICINE, 366(23), 2180-2188.
  
• Mutations in the Kinetochore Gene KNSTRN in Basal Cell Carcinoma. Jaju, P. D., Nguyen, C. B., Mah, A. M., Atwood, S. X., Li, J., & Sarin, K. Y. (2015). Mutations in the Kinetochore Gene KNSTRN in Basal Cell Carcinoma. journal of investigative dermatology, 135(12), 3197-3200.
  
• Smoothened Inhibitors in Sonic Hedgehog Subgroup Medulloblastoma. Ransohoff, K. J., Sarin, K. Y., & Tang, J. Y. (2015). Smoothened Inhibitors in Sonic Hedgehog Subgroup Medulloblastoma. Journal of clinical oncology , 33(24), 2692-2694.
  
• Rolling the Genetic Dice: Neutral and Deleterious Smoothened Mutations in Drug-Resistant Basal Cell Carcinoma. Atwood, S. X., Sarin, K. Y., Li, J. R., Yao, C. Y., Urman, N. M., & Oro, A. E. (2015). Rolling the Genetic Dice: Neutral and Deleterious Smoothened Mutations in Drug-Resistant Basal Cell Carcinoma. journal of investigative dermatology, 135(8), 2138-2141.
  
• Pilot study on the bioactivity of vitamin d in the skin after oral supplementation. Curiel-Lewandrowski, C., Tang, J. Y., Einspahr, J. G., Bermudez, Y., Hsu, C. H., & Chow, H.-H. S. (2015). Pilot study on the bioactivity of vitamin d in the skin after oral supplementation. Cancer prevention research , 8(6), 563-569.
  
• A new functional validation assay to measure resistance drivers in patient BCCs Whitson, R., Atwood, S., SARIN, K., Li, J., Kim, G., & Oro, A. (2015). A new functional validation assay to measure resistance drivers in patient BCCs. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 135, S23-S23.
  
• Detection of Non-Melanoma Skin Cancer by in vivo Fluorescence Imaging with Fluorocoxib A. Ra, H., González-González, E., Uddin, M. J., King, B. L., Lee, A., & Contag, C. H. (2015). Detection of Non-Melanoma Skin Cancer by in vivo Fluorescence Imaging with Fluorocoxib A. Neoplasia , 17(2), 201-207.
  
• Smoking behavior and association of melanoma and nonmelanoma skin cancer in the Women's Health Initiative Henderson, M. T., Kubo, J. T., Desai, M., David, S. P., Tindle, H., & Tang, J. Y. (2015). Smoking behavior and association of melanoma and nonmelanoma skin cancer in the Women's Health Initiative. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 72(1), 190-191.
  
• Effect of Calcium Channel Blockade on Vismodegib-Induced Muscle Cramps. Ally, M. S., Tang, J. Y., Lindgren, J., Acosta-Raphael, M., Rezaee, M., & Epstein, E. H. (2015). Effect of Calcium Channel Blockade on Vismodegib-Induced Muscle Cramps. JAMA dermatology.
  
• Non-melanoma skin cancer and NSAID use in women with a history of skin cancer in the Women's Health Initiative Wysong, A., Ally, M. S., Gamba, C. S., Desai, M., Swetter, S. M., & Tang, J. Y. (2014). Non-melanoma skin cancer and NSAID use in women with a history of skin cancer in the Women's Health Initiative. PREVENTIVE MEDICINE, 69, 8-12.
  
• Vitamin D levels and menopause-related symptoms LeBlanc, E. S., Desai, M., Perrin, N., Wactawski-Wende, J., Manson, Ja. E., & Stefanick, M. L. (2014). Vitamin D levels and menopause-related symptoms. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 21(11), 1197-1203.
  
• An investigator-initiated open-label clinical trial of vismodegib as a neoadjuvant to surgery for high-risk basal cell carcinoma. Ally, M. S., Aasi, S., Wysong, A., Teng, C., Anderson, E., & Tang, J. Y. (2014). An investigator-initiated open-label clinical trial of vismodegib as a neoadjuvant to surgery for high-risk basal cell carcinoma. Journal of the American Academy of Dermatology, 71(5), 904-911 e1.
  
• Dermatologic applications of direct-to-consumer genomic analysis. Fogel, A. L., Azizi, N., Tang, J., & Sarin, K. Y. (2014). Dermatologic applications of direct-to-consumer genomic analysis. Journal of the American Academy of Dermatology, 71(5), 993-995.
  
• Non-steroidal anti-inflammatory drugs and cancer risk in women: Results from the Women's Health Initiative Brasky, T. M., Liu, J., White, E., Peters, U., Potter, J. D., & Wactawski-Wende, J. (2014). Non-steroidal anti-inflammatory drugs and cancer risk in women: Results from the Women's Health Initiative. INTERNATIONAL JOURNAL OF CANCER, 135(8), 1869-1883.
  
• Automated identification of basal cell carcinoma by polarization-sensitive optical coherence tomography Duan, L., Marvdashti, T., Lee, A., Tang, J. Y., & Ellerbee, A. K. (2014). Automated identification of basal cell carcinoma by polarization-sensitive optical coherence tomography. BIOMEDICAL OPTICS EXPRESS, 5(10), 3717-3729.
  
• Preclinical study to develop smoothened inhibitor resistant basal cell carcinomas in mice Lee, A., Whitson, R., Rezaee, M., Chanana, A., Epstein, E., & Tang, J. Y. (2014). Preclinical study to develop smoothened inhibitor resistant basal cell carcinomas in mice. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 134(8), S8-S8.
  
• Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition. Tang, Y., Gholamin, S., Schubert, S., Willardson, M. I., Lee, A., & Cho, Y.-J. (2014). Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition. Nature medicine, 20(7), 732-740.
  
• Lack of efficacy with 1064-nm neodymium: yttrium-aluminum-garnet laser for the treatment of onychomycosis: A randomized, controlled trial Hollmig, S. T., Rahman, Z., Henderson, M. T., Rotatori, R. M., Gladstone, H., & Tang, J. Y. (2014). Lack of efficacy with 1064-nm neodymium: yttrium-aluminum-garnet laser for the treatment of onychomycosis: A randomized, controlled trial. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 70(5), 911-917.
  
• The Use of Vismodegib to Shrink Keratocystic Odontogenic Tumors in Patients With Basal Cell Nevus Syndrome Ally, M. S., Tang, J. Y., Joseph, T., Thompson, B., Lindgren, J., & Epstein, E. H. (2014). The Use of Vismodegib to Shrink Keratocystic Odontogenic Tumors in Patients With Basal Cell Nevus Syndrome. JAMA DERMATOLOGY, 150(5), 542-545.
  
• Network geometry shows evidence sequestration for medical vs. surgical practices: treatments for basal cell carcinoma Kim, D. D., Tang, J. Y., & Ioannidis, J. Pa. (2014). Network geometry shows evidence sequestration for medical vs. surgical practices: treatments for basal cell carcinoma. JOURNAL OF CLINICAL EPIDEMIOLOGY, 67(4), 391-400.
  
• Tazarotene: Randomized, Double-Blind, Vehicle-Controlled, and Open-Label Concurrent Trials for Basal Cell Carcinoma Prevention and Therapy in Patients with Basal Cell Nevus Syndrome Tang, J. Y., Chiou, A. S., Mackay-Wiggan, J. M., Aszterbaum, M., Chanana, A. M., & Epstein, E. H. (2014). Tazarotene: Randomized, Double-Blind, Vehicle-Controlled, and Open-Label Concurrent Trials for Basal Cell Carcinoma Prevention and Therapy in Patients with Basal Cell Nevus Syndrome. CANCER PREVENTION RESEARCH, 7(3), 292-299.
  
• Alcohol consumption and risk of melanoma and non-melanoma skin cancer in the Women's Health Initiative Kubo, J. T., Henderson, M. T., Desai, M., Wactawski-Wende, J., Stefanick, M. L., & Tang, J. Y. (2014). Alcohol consumption and risk of melanoma and non-melanoma skin cancer in the Women's Health Initiative. CANCER CAUSES & CONTROL, 25(1), 1-10.
  
• Eczema and Sensitization to Common Allergens in the United States: A Multiethnic, Population-Based Study Fu, T., Keiser, E., Linos, E., Rotatori, R. M., Sainani, K., & Tang, J. Y. (2014). Eczema and Sensitization to Common Allergens in the United States: A Multiethnic, Population-Based Study. PEDIATRIC DERMATOLOGY, 31(1), 21-26.
  
• Quantifying Soft Tissue Loss in Facial Aging: A Study in Women Using Magnetic Resonance Imaging Wysong, A., Joseph, T., Kim, D., Tang, J. Y., & Gladstone, H. B. (2013). Quantifying Soft Tissue Loss in Facial Aging: A Study in Women Using Magnetic Resonance Imaging. DERMATOLOGIC SURGERY, 39(12), 1895-1902.
  
• Lower Skin Cancer Risk in Women with Higher Body Mass Index: The Women's Health Initiative Observational Study Tang, J. Y., Henderson, M. T., Hernandez-Boussard, T., Kubo, J., Desai, M., & Stefanick, M. L. (2013). Lower Skin Cancer Risk in Women with Higher Body Mass Index: The Women's Health Initiative Observational Study. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 22(12), 2412-2415.
  
• Role of aspirin and non-aspirin NSAIDs in preventing melanoma. Ally, M. S., Swetter, S. M., & Tang, J. Y. (2013). Role of aspirin and non-aspirin NSAIDs in preventing melanoma. Future oncology , 9(11), 1671-1674.
  
• Low-Fat Diet and Skin Cancer Risk: The Women's Health Initiative Randomized Controlled Dietary Modification Trial Gamba, C. S., Stefanick, M. L., Shikany, J. M., Larson, J., Linos, E., & Tang, J. Y. (2013). Low-Fat Diet and Skin Cancer Risk: The Women's Health Initiative Randomized Controlled Dietary Modification Trial. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 22(9), 1509-1519.
  
• Cutaneous human papillomavirus infection and Basal cell carcinoma of the skin. Ally, M. S., Tang, J. Y., & Arron, S. T. (2013). Cutaneous human papillomavirus infection and Basal cell carcinoma of the skin. journal of investigative dermatology, 133(6), 1456-1458.
  
• The use of aprepitant in brachioradial pruritus. Ally, M. S., Gamba, C. S., Peng, D. H., & Tang, J. Y. (2013). The use of aprepitant in brachioradial pruritus. JAMA dermatology (Chicago, Ill.), 149(5), 627-628.
  
• Lower serum vitamin D levels are associated with increased risk of eczema in US adults Fu, T., Gamba, C., IVE, H., & Tang, J. Y. (2013). Lower serum vitamin D levels are associated with increased risk of eczema in US adults. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 133, S93-S93.
  
• Vismodegib as an adjuvant to surgery for basal cell carcinomas ALLY, M. S., Aasi, S., Chang, A., Teng, C., Anderson, E. M., & Tang, J. Y. (2013). Vismodegib as an adjuvant to surgery for basal cell carcinomas. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 133, S178-S178.
  
• Update on metastatic basal cell carcinoma: a summary of published cases from 1981 through 2011. Wysong, A., Aasi, S. Z., & Tang, J. Y. (2013). Update on metastatic basal cell carcinoma: a summary of published cases from 1981 through 2011. JAMA dermatology , 149(5), 615-616.
  
• Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women The Women's Health Initiative Gamba, C. A., Swetter, S. M., Stefanick, M. L., Kubo, J., Desai, M., & Tang, J. Y. (2013). Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women The Women's Health Initiative. CANCER, 119(8), 1562-1569.
  
• Nonmelanoma Skin Cancer Visits and Procedure Patterns in a Nationally Representative Sample: National Ambulatory Medical Care Survey 1995-2007 Wysong, A., Linos, E., Hernandez-Boussard, T., Arron, S. T., Gladstone, H., & Tang, J. Y. (2013). Nonmelanoma Skin Cancer Visits and Procedure Patterns in a Nationally Representative Sample: National Ambulatory Medical Care Survey 1995-2007. DERMATOLOGIC SURGERY, 39(4), 596-602.
  
• GLI activation by atypical protein kinase C iota/lambda regulates the growth of basal cell carcinomas Atwood, S. X., Li, M., Lee, A., Tang, J. Y., & Oro, A. E. (2013). GLI activation by atypical protein kinase C iota/lambda regulates the growth of basal cell carcinomas. NATURE, 494(7438), 484-488.
  
• New Onset of Keratoacanthomas After Vismodegib Treatment for Locally Advanced Basal Cell Carcinomas: A Report of 2 Cases Aasi, S., Silkiss, R., Tang, J. Y., Wysong, A., Liu, A., & Chang, A. L. S. (2013). New Onset of Keratoacanthomas After Vismodegib Treatment for Locally Advanced Basal Cell Carcinomas: A Report of 2 Cases. JAMA DERMATOLOGY, 149(2), 242-243.
  
• Factors affecting sunscreen use and sun avoidance in a US national sample of organ transplant recipients Mihalis, E. L., Wysong, A., Boscardin, W. J., Tang, J. Y., Chren, M. M., & Arron, S. T. (2013). Factors affecting sunscreen use and sun avoidance in a US national sample of organ transplant recipients. BRITISH JOURNAL OF DERMATOLOGY, 168(2), 346-353.
  
• Itraconazole and Arsenic Trioxide Inhibit Hedgehog Pathway Activation and Tumor Growth Associated with Acquired Resistance to Smoothened Antagonists Kim, J., Aftab, B. T., Tang, J. Y., Kim, D., Lee, A. H., & Rudin, C. M. (2013). Itraconazole and Arsenic Trioxide Inhibit Hedgehog Pathway Activation and Tumor Growth Associated with Acquired Resistance to Smoothened Antagonists. CANCER CELL, 23(1), 23-34.
  
• The Evolving Conception and Management Challenges of Malignant Fibrous Histiocytoma Hollmig, S. T., Kirkland, E. B., Henderson, M. T., Tang, J. Y., & Gladstone, H. B. (2012). The Evolving Conception and Management Challenges of Malignant Fibrous Histiocytoma. DERMATOLOGIC SURGERY, 38(12), 1922-1929.
  
• Is Tanning Bed Exposure Associated With Aggressive Basal Cell Carcinoma? Gamba, C. A., Wysong, A., Million, L., Aasi, S., Kim, J., & Tang, J. Y. (2012). Is Tanning Bed Exposure Associated With Aggressive Basal Cell Carcinoma?. JOURNAL OF CLINICAL ONCOLOGY, 30(32), E333-E336.
  
• Sunscreen use in NCAA collegiate athletes: Identifying targets for intervention and barriers to use Wysong, A., Gladstone, H., Kim, D., Lingala, B., Copeland, J., & Tang, J. Y. (2012). Sunscreen use in NCAA collegiate athletes: Identifying targets for intervention and barriers to use. PREVENTIVE MEDICINE, 55(5), 493-496.
  
• Vitamin D in cutaneous carcinogenesis Part II Tang, J. Y., Fu, T., Lau, C., Oh, D. H., Bikle, D. D., & Asgari, M. M. (2012). Vitamin D in cutaneous carcinogenesis Part II. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 67(5).
  
• Vitamin D in cutaneous carcinogenesis Part I Tang, J. Y., Fu, T., Lau, C., Oh, D. H., Bikle, D. D., & Asgari, M. M. (2012). Vitamin D in cutaneous carcinogenesis Part I. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 67(5).
  
• Does a History of Eczema Predict a Future Basal Cell Carcinoma? Gamba, C. A., & Tang, J. Y. (2012). Does a History of Eczema Predict a Future Basal Cell Carcinoma?. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 132(11), 2497-2499.
  
• Nanoelectroablation therapy for murine basal cell carcinoma Nuccitelli, R., Kevin Tran, K., Athos, B., Kreis, M., Nuccitelli, P., & Tang, J. Y. (2012). Nanoelectroablation therapy for murine basal cell carcinoma. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 424(3), 446-450.
  
• Pachyonychia congenita patients with mutations in KRT6A have more extensive disease compared with patients who have mutations in KRT16 Spaunhurst, K. M., Hogendorf, A. M., Smith, F. Jd., Lingala, B., Schwartz, M. E., & Tang, J. Y. (2012). Pachyonychia congenita patients with mutations in KRT6A have more extensive disease compared with patients who have mutations in KRT16. BRITISH JOURNAL OF DERMATOLOGY, 166(4), 875-878.
  
• Ulcers and stellate scars on bilateral ankles. Spaunhurst, K. M., Wysong, A., Kim, J., & Tang, J. Y. (2012). Ulcers and stellate scars on bilateral ankles. Archives of dermatology, 148(3), 385-390.
  
• Vitamin D in cutaneous carcinogenesis: part II. Tang, J. Y., Fu, T., Lau, C., Oh, D. H., Bikle, D. D., & Asgari, M. M. (2012). Vitamin D in cutaneous carcinogenesis: part II. Journal of the American Academy of Dermatology, 67(5), 817.e1-11; quiz 827-8.
  
• Sun protective behaviors and vitamin D levels in the US population: NHANES 2003-2006 Linos, E., Keiser, E., Kanzler, M., Sainani, K. L., Lee, W., & Tang, J. Y. (2012). Sun protective behaviors and vitamin D levels in the US population: NHANES 2003-2006. CANCER CAUSES & CONTROL, 23(1), 133-140.
  
• Reliability and prevalence of digital image skin types in the United States: Results from National Health and Nutrition Examination Survey 2003-2004 Keiser, E., Linos, E., Kanzler, M., Lee, W., Sainani, K. L., & Tang, J. Y. (2012). Reliability and prevalence of digital image skin types in the United States: Results from National Health and Nutrition Examination Survey 2003-2004. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 66(1), 163-165.
  
• Emerging Treatments and Signaling Pathway Inhibitors Tang, J. Y., & Marghoob, A. A. (2011). Emerging Treatments and Signaling Pathway Inhibitors. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 30(4), S14-S18.
  
• Elucidating the Role of Molecular Signaling Pathways in the Tumorigenesis of Basal Cell Carcinoma Tang, J. Y. (2011). Elucidating the Role of Molecular Signaling Pathways in the Tumorigenesis of Basal Cell Carcinoma. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 30(4), S6-S9.
  
• Correlates of low bone mass in children with generalized forms of epidermolysis bullosa Bruckner, A. L., Bedocs, L. A., Keiser, E., Tang, J. Y., Doernbrack, C., & Bachrach, L. K. (2011). Correlates of low bone mass in children with generalized forms of epidermolysis bullosa. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 65(5), 1001-1009.
  
• Menopausal Hormone Therapy and Risks of Melanoma and Nonmelanoma Skin Cancers: Women's Health Initiative Randomized Trials Tang, J. Y., Spaunhurst, K. M., Chlebowski, R. T., Wactawski-Wende, J., Keiser, E., & Stefanick, M. L. (2011). Menopausal Hormone Therapy and Risks of Melanoma and Nonmelanoma Skin Cancers: Women's Health Initiative Randomized Trials. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 103(19), 1469-1475.
  
• Subcutaneous Nodules in an Elderly Patient Necrobiotic xanthogranuloma Fu, T., Zwerner, J., Kim, J., & Tang, J. (2011). Subcutaneous Nodules in an Elderly Patient Necrobiotic xanthogranuloma. ARCHIVES OF DERMATOLOGY, 147(10), 1215-1220.
  
• Calcium Plus Vitamin D Supplementation and the Risk of Nonmelanoma and Melanoma Skin Cancer: Post Hoc Analyses of the Women's Health Initiative Randomized Controlled Trial Tang, J. Y., Fu, T., Leblanc, E., Manson, Ja. E., Feldman, D., & Stefanick, M. L. (2011). Calcium Plus Vitamin D Supplementation and the Risk of Nonmelanoma and Melanoma Skin Cancer: Post Hoc Analyses of the Women's Health Initiative Randomized Controlled Trial. JOURNAL OF CLINICAL ONCOLOGY, 29(22), 3078-3084.
  
• Hat, shade, long sleeves, or sunscreen? Rethinking US sun protection messages based on their relative effectiveness Linos, E., Keiser, E., Fu, T., Colditz, G., Chen, S., & Tang, J. Y. (2011). Hat, shade, long sleeves, or sunscreen? Rethinking US sun protection messages based on their relative effectiveness. CANCER CAUSES & CONTROL, 22(7), 1067-1071.
  
• Targeting Superficial or Nodular Basal Cell Carcinoma with Topically Formulated Small Molecule Inhibitor of Smoothened Tang, T., Tang, J. Y., Li, D., Reich, M., Callahan, C. A., & de Sauvage, F. J. (2011). Targeting Superficial or Nodular Basal Cell Carcinoma with Topically Formulated Small Molecule Inhibitor of Smoothened. CLINICAL CANCER RESEARCH, 17(10), 3378-3387.
  
• Genotype-Phenotype Correlations among Pachyonychia Congenita Patients with K16 Mutations Fu, T., Leachman, S. A., Wilson, N. J., Smith, F. Jd., Schwartz, M. E., & Tang, J. Y. (2011). Genotype-Phenotype Correlations among Pachyonychia Congenita Patients with K16 Mutations. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 131(5), 1025-1028.
  
• Vitamin D3 Inhibits Hedgehog Signaling and Proliferation in Murine Basal Cell Carcinomas Tang, J. Y., Xiao, T. Z., Oda, Y., Chang, K. S., Shpall, E., & Epstein, E. H. (2011). Vitamin D3 Inhibits Hedgehog Signaling and Proliferation in Murine Basal Cell Carcinomas. CANCER PREVENTION RESEARCH, 4(5), 744-751.
  
• Association of facial skin aging and vitamin D levels in middle-aged white women Chang, A. L. S., Fu, T., Amir, O., & Tang, J. Y. (2010). Association of facial skin aging and vitamin D levels in middle-aged white women. CANCER CAUSES & CONTROL, 21(12), 2315-2316.
  
• High Prevalence of Vitamin D Deficiency in Patients With Basal Cell Nevus Syndrome Tang, J. Y., Wu, A., Linos, E., Parimi, N., Lee, W., & Epstein, E. H. (2010). High Prevalence of Vitamin D Deficiency in Patients With Basal Cell Nevus Syndrome. ARCHIVES OF DERMATOLOGY, 146(10), 1105-1110.
  
• Novel investigational drugs for basal cell carcinoma So, P.-L., Tang, J. Y., & Epstein, E. H. (2010). Novel investigational drugs for basal cell carcinoma. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 19(9), 1099-1112.
  
• Association of Prediagnostic Serum Vitamin D Levels with the Development of Basal Cell Carcinoma Asgari, M. M., Tang, J., Warton, M. E., Chren, M.-M., Quesenberry, C. P., & Friedman, G. D. (2010). Association of Prediagnostic Serum Vitamin D Levels with the Development of Basal Cell Carcinoma. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 130(5), 1438-1443.
  
• Itraconazole, a Commonly Used Antifungal that Inhibits Hedgehog Pathway Activity and Cancer Growth Kim, J., Tang, J. Y., Gong, R., Kim, J., Lee, J. J., & Beachy, P. A. (2010). Itraconazole, a Commonly Used Antifungal that Inhibits Hedgehog Pathway Activity and Cancer Growth. CANCER CELL, 17(4), 388-399.
  
• Cytologic "touch preparation" analysis of skin biopsies for rapid evaluation of malignant skin diseases Sun, B., Ohgami, R., Sundram, U., Schwartz, E., & Tang, J. (2010). Cytologic "touch preparation" analysis of skin biopsies for rapid evaluation of malignant skin diseases. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 130, S52-S52.
  
• Inverse association between serum 25(OH) vitamin D levels and non-melanoma skin cancer in elderly men Tang, J. Y., Parimi, N., Wu, A., Boscardin, W. J., Shikany, J. M., & Bauer, D. C. (2010). Inverse association between serum 25(OH) vitamin D levels and non-melanoma skin cancer in elderly men. CANCER CAUSES & CONTROL, 21(3), 387-391.
  
• Touch Preparation Analysis of Skin Lesions Is a Rapid, Accurate Diagnostic Technique: A Prospective Clinical-Pathologic Study Ohgami, R. S., Sun, B., Kosek, J., Tang, J., Chen, S., & Schwartz, E. J. (2010). Touch Preparation Analysis of Skin Lesions Is a Rapid, Accurate Diagnostic Technique: A Prospective Clinical-Pathologic Study. MODERN PATHOLOGY, 23, 120A-120A.
  
• Medical Management of Advanced or Metastatic Basal Cell Carcinomas Jean Y Tang, & Ervin H. Epstein. (2010). Medical Management of Advanced or Metastatic Basal Cell Carcinomas. AccessMedicine from McGraw-Hill.
  
• Basal Cell Carcinoma Chemoprevention with Nonsteroidal Anti-inflammatory Drugs in Genetically Predisposed PTCH1(+/-) Humans and Mice Tang, J. Y., Aszterbaum, M., Athar, M., Barsanti, F., Cappola, C., & Epstein, E. H. (2010). Basal Cell Carcinoma Chemoprevention with Nonsteroidal Anti-inflammatory Drugs in Genetically Predisposed PTCH1(+/-) Humans and Mice. CANCER PREVENTION RESEARCH, 3(1), 25-34.
  
• Statin use and risk of basal cell carcinoma Asgari, M. A., Tang, J., Epstein, E. H., Chren, M.-M., Warton, E. M., & Friedman, G. D. (2009). Statin use and risk of basal cell carcinoma. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 61(1), 66-72.
  
• Novel Hedgehog pathway targets against basal cell carcinoma Tang, J. Y., So, P.-L., & Epstein, E. H. (2007). Novel Hedgehog pathway targets against basal cell carcinoma. TOXICOLOGY AND APPLIED PHARMACOLOGY, 224(3), 257-264.
  
• Xeroderma pigmentosum group C in an isolated region of Guatemala Cleaver, J. E., Feeney, L., Tang, J. Y., & Tuttle, P. (2007). Xeroderma pigmentosum group C in an isolated region of Guatemala. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 127(2), 493-496.
  
• Toxicity from radiation therapy associated with abnormal transcriptional responses to DNA damage Rieger, K. E., Hong, W. J., Tusher, V. G., Tang, J., Tibshirani, R., & Chu, G. (2004). Toxicity from radiation therapy associated with abnormal transcriptional responses to DNA damage. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 101(17), 6635-6640.
  
• Interaction between UV-damaged DNA binding activity proteins and the c-Abl tyrosine kinase Cong, F., Tang, J., Hwang, B. J., Vuong, B. Q., Chu, G., & Goff, S. P. (2002). Interaction between UV-damaged DNA binding activity proteins and the c-Abl tyrosine kinase. JOURNAL OF BIOLOGICAL CHEMISTRY, 277(38), 34870-34878.
  
• Xeroderma pigmentosum complementation group E and UV-damaged DNA-binding protein Tang, J., & Chu, G. (2002). Xeroderma pigmentosum complementation group E and UV-damaged DNA-binding protein. DNA REPAIR, 1(8), 601-616.
  
• Xeroderma pigmentosum p48 gene enhances global genomic repair and suppresses UV-induced mutagenesis Tang, J. Y., Hwang, B. J., Ford, J. M., Hanawalt, P. C., & Chu, G. (2000). Xeroderma pigmentosum p48 gene enhances global genomic repair and suppresses UV-induced mutagenesis. MOLECULAR CELL, 5(4), 737-744.
  
• INHIBITION OF LECITHIN-CHOLESTEROL ACYLTRANSFERASE AND MODIFICATION OF HDL APOLIPOPROTEINS BY ALDEHYDES McCall, M., Tang, J. Y., Bielicki, J. K., & Forte, T. M. (1995). INHIBITION OF LECITHIN-CHOLESTEROL ACYLTRANSFERASE AND MODIFICATION OF HDL APOLIPOPROTEINS BY ALDEHYDES. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 15(10), 1599-1606.